Comparative effect of dihydroartemisinin-piperaquine and artemether-lumefantrine on gametocyte clearance and haemoglobin recovery in children with uncomplicated Plasmodium falciparum malaria in Africa: a systematic review and meta-analysis of randomized control trials

被引:3
|
作者
Assefa, Dawit Getachew [1 ,2 ]
Yismaw, Gizachew [1 ]
Makonnen, Eyasu [1 ,3 ]
机构
[1] Addis Ababa Univ, Coll Hlth Sci, Ctr Innovat Drug Dev & Therapeut Trials Africa, Addis Ababa 9087, Ethiopia
[2] Dilla Univ, Coll Hlth Sci & Med, Dept Nursing, Dilla, Ethiopia
[3] Addis Ababa Univ, Coll Hlth Sci, Dept Pharmacol & Clin Pharm, Addis Ababa, Ethiopia
关键词
Dihydroartemisinin-piperaquine; Artemether-lumefantrine; Systematic review and meta-analysis; Africa; RISK-FACTORS; COMBINATION TREATMENTS; CARRIAGE; TRANSMISSION; ANEMIA; EFFICACY;
D O I
10.1016/j.ijid.2021.10.013
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Plasmodium falciparum gametocytaemia has been associated with anaemia. The aim of this review was to synthesize available evidence on the comparative effect of dihydroartemisinin-piperaquine (DHA-PQ) and artemether-lumefantrine (AL) on gametocyte clearance and haemoglobin recovery in chil-dren with uncomplicated P. falciparum malaria in Africa. Methods: A systematic literature search was undertaken to identify relevant articles from online databases. The search was performed from August 2020 to 30 April 2021. Extracted data from eligible studies were pooled as risk ratios with 95% confidence intervals (CI). Results: Gametocyte carriage was reduced in both treatment groups, with no significant difference found between the groups. However, on days 28 and 42, a significant increase in serum haemoglobin level from baseline was observed in the DHA-PQ group (standardized mean difference 0.15, 95% CI 0.05-0.26; participants = 2715; studies = 4; I 2 = 32%, high quality of evidence) compared with the AL group (mean dif-ference 0.35, 95% CI 0.12-0.59; participants = 1434; studies = 3; I 2 = 35%, high quality of evidence). Conclusion: DHA-PQ had a greater impact on haemoglobin recovery than AL on days 28 and 42; this difference was significant. (c) 2021 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. This is an open access article under the CC BY license ( http://creativecommons.org/licenses/by/4.0/ )
引用
收藏
页码:136 / 147
页数:12
相关论文
共 50 条
  • [31] Recurrence of Plasmodium malariae and P. falciparum Following Treatment of Uncomplicated Malaria in North Sumatera With Dihydroartemisinin-Piperaquine or Artemether-Lumefantrine
    Lubis, Inke Nadia D.
    Wijaya, Hendri
    Lubis, Munar
    Lubis, Chairuddin P.
    Beshir, Khalid B.
    Staedke, Sarah G.
    Sutherland, Colin J.
    OPEN FORUM INFECTIOUS DISEASES, 2020, 7 (05):
  • [32] Multicentric assessment of the efficacy and tolerability of dihydroartemisinin-piperaquine compared to artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in sub-Saharan Africa
    Yavo, William
    Faye, Babacar
    Kuete, Thomas
    Djohan, Vincent
    Oga, Serge A.
    Kassi, Richard R.
    Diatta, Mariama
    Ama, Moor V.
    Tine, Roger
    Ndiaye, Jean-Louis
    Evi, Jean-Bedel
    Same-Ekobo, Albert
    Faye, Oumar
    Kone, Moussa
    MALARIA JOURNAL, 2011, 10
  • [33] Randomized comparison of amodiaquine plus sulfadoxine-pyrimethamine, artemether-lumefantrine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Burkina Faso
    Zongo, Issaka
    Dorsey, Grant
    Rouamba, Noel
    Dokomajilar, Christian
    Sere, Yves
    Rosenthal, Philip J.
    Ouedraogo, Jean Bosco
    CLINICAL INFECTIOUS DISEASES, 2007, 45 (11) : 1453 - 1461
  • [34] Safety and efficacy of dihydroartemisinin-piperaquine versus artemether-lumefantrine in the treatment of uncomplicated P. falciparum malaria in Zambian children
    Nambozi, M.
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2012, 17 : 41 - 41
  • [35] Acceptability and comparative efficacy of artemether-lumefantrine vs. dihydroartemisinin/piperaquine in Kenyan children with uncomplicated falciparum malaria
    Onyango, K. O.
    Ongecha, J. M.
    Juma, E.
    Otieno, G. A.
    Obonyo, C.
    Otieno, L.
    Perkins, D. J.
    Akhwale, W.
    Ogutu, B.
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2011, 16 : 110 - 110
  • [36] EFFECT OF DIHYDROARTEMISININ-PIPERAQUINE AND ARTEMETHER-LUMEFANTRINE WITH AND WITHOUT PRIMAQUINE ON PLASMODIUM VIVAX RECURRENCE: A SYSTEMATIC REVIEW AND INDIVIDUAL PATIENT DATA META-ANALYSIS
    Commons, Robert J.
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2019, 101 : 487 - 487
  • [37] Randomized comparison of amodiaquine-sulfadoxine/pyrimethamine, artemether-lumefantrine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated falciparum malaria in Burkina Faso
    Zongo, Issaka
    Grant, Dorsey
    Rouamba, Noel
    Dokomajilar, Christian
    Sere, Yves
    Rosenthal, Philip J.
    Ouedraogo, Jean Bosco
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2007, 77 (05): : 122 - 122
  • [38] Therapeutic efficacy of artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Ethiopia: a systematic review and meta-analysis
    Mohammed Biset Ayalew
    Infectious Diseases of Poverty, 6
  • [39] Therapeutic efficacy of artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Ethiopia: a systematic review and meta-analysis
    Ayalew, Mohammed Biset
    INFECTIOUS DISEASES OF POVERTY, 2017, 6
  • [40] Efficacy and safety of artemether-lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Ethiopia: a systematic review and meta-analysis
    Abamecha, Abdulhakim
    Yilma, Daniel
    Adissu, Wondimagegn
    Yewhalaw, Delenasaw
    Abdissa, Alemseged
    MALARIA JOURNAL, 2021, 20 (01)